Buscar
Mostrando ítems 1-10 de 10
Small-molecule aggregation inhibitors reduce excess amyloid in a trisomy 16 mouse cortical cell line
(Sociedad de Biología de Chile, 2008)
Altered calcium currents in cultured sensory neurons of normal and trisomy 16 mouse fetuses, an animal model for human trisomy 21 (Down Syndrome)
(SOCIEDAD BIOLGIA CHILE, 2006)
Down syndrome is determined by the presence of an extra copy of autosome 21 and is expressed by multiple abnormalities, with mental retardation being the most striking feature. The condition results in altered electrical ...
A dorsal root ganglia cell line derived from trisomy 16 fetal mice, a model for Down syndrome
(Lippincott Williams and Wilkins, 2002)
We have established two immortalized cell lines from dorsal root ganglia of normal (G4b) and trisomy 16 mice (GTI), a model for Down syndrome. By immunohistochemistry, both cell lines exhibit neuronal traits and lack glial ...
Apoptosis is directly related to intracellular amyloid accumulation in a cell line derived from the cerebral cortex of a trisomy 16 mouse, an animal model of Down syndrome
(ELSEVIER, 2010)
Human Down syndrome (DS) represents the most frequent cause of mental retardation associated to
a genetic condition. DS also exhibits a characteristic early onset of neuropathology indistinguishable
from that observed ...
Neuronal dysfunction in Down syndrome: Contribution of neuronal models in cell culture
(ELSEVIER, 2006-05)
Down syndrome (DS) in humans, or trisomy of autosome 21, represents the hyperdiploidy that most frequently survives gestation, reaching an incidence of I in 700 live births. The condition is associated with multisystemic ...
Role of Tau Protein in Neuronal Damage in Alzheimer's Disease and Down Syndrome
(Elsevier, 2012)
Neurodegenerative disorders constitute a growing concern worldwide. Their incidence
has increased steadily, in particular among the elderly, a high-risk population that is
becoming an important segment of society. ...
Pluripotent Stem Cells Reveal Erythroid-specific Activities Of The Gata1 N-terminus
(AMER SOC CLINICAL INVESTIGATION INCANN ARBOR, 2015)
Aplicaciones médicas de las células pluripotentes inducidas paciente-específicas
(Universidad Militar Nueva Granada, 2013)
Aplicaciones médicas de las células pluripotentes inducidas paciente-específicas
(Universidad Militar Nueva Granada, 2013)